Ceftibuten dihydrate, a third-generation cephalosporin antibiotic, is the dihydrate form of ceftibuten which is a semisynthetic, beta-lactamase-stable, cephalosporin with antibacterial activity.

Vaborbactam (formerly PX-7009; MP-7009; RPX7009; trade name: Vabomere) is novel, potent and broad spectrum non-β-lactam (cyclic boronic acid pharmacophore) β-lactamase inhibitor discovered by Rempex Pharmaceuticals and approved in 2017 for the treatment of complicated urinary tract infections and pyelonephritis.

Calcimycin (A-23187) is an antibiotic isolated from Streptomyces chartreusensis.

Flucloxacillin sodium (Floxacillin, Floxapen) is a potent narrow-spectrum beta-lactam antibiotic used to treat infections caused by susceptible Gram-positive bacteria.

Fosfomycin sodium(also known as MK-955) is an antibiotic. USP grade with 720IU/mg

Neotuberostemonine is a novel and potent antitussive alkaloid.

Omadacycline mesylate (Nuzyra), the mesylate salt of omadacycline, is an aminomethyl tetracycline antibiotic approved in Oct 2018 by FDA to treat community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.

Brodimoprim (Ro-105970) is an analogue of trimethoprim and is an orally bioactive and long-acting DHFR/dihydrofolate reductase inhibitor with activity against a broad spectrum of gram-negative and gram-positive bacteria.

Josamycin (BRN-1677122; CCRIS 8511; EN-141) is a macrolide antibiotic that exhibits antimicrobial activity against a wide spectrum of pathogens, such as bacteria. The dissociation constant Kd from ribosome for Josamycin is 5.5 nM. It is synthesized from strains of Streptomyces narbonensis var.

TBA-354, formerly known as SN31354, is a potent anti-tuberculosis drug candidate.